Literature DB >> 28577872

Association of Adiponectin with Subclinical Atherosclerosis in a Mexican-Mestizo Population.

Juan Gabriel Juárez-Rojas1, Rosalinda Posadas-Sánchez1, María Del Rocío Martínez-Alvarado1, Margarita Torres-Tamayo1, Esteban Jorge-Galarza1, Erika Yamel Mancilla-Valenzuela1, Carlos Posadas-Romero1, Guillermo Celestino Cardoso-Saldaña1, María Del Carmen González-Salazar1, Gilberto Vargas-Alarcón2, Aida Xochitl Medina-Urrutia3.   

Abstract

BACKGROUND AND AIMS: Adiponectin (ADPN) is a cardioprotective adipocytokine, and its association with atherosclerosis development is controversial. The aim of the present study was to assess the association of low ADPN plasma levels with the presence of subclinical atherosclerosis in a Mexican-Mestizo population without history of diabetes or coronary artery disease (CAD).
METHODS: In 818 subjects (53.4 ± 9 years; 49.9% women) anthropometry, subcutaneous and visceral adipose tissue, lipids, glucose, C-reactive protein (CRP), insulin, and ADPN levels were determined. Carotid artery intima-media thickness (CIMT) was measured with ultrasound in B mode and the sex-age specific value higher than 75th percentile defined the presence of subclinical atherosclerosis. Low ADPN was considered when plasma concentrations were lower than 25th percentile (8.67 μg/mL in women, 5.30 μg/mL in men).
RESULTS: Prevalence of low ADPN was 43.6% (42.9% in women and 44.4% in men; p = 0.66) and elevated CIMT (eCIMT) was 23.8% (25.8% in women and 21.9% in men; p = 0.184). In addition to their higher prevalence of low ADPN, subjects with eCIMT had higher values of body mass index, blood pressure, total cholesterol, triglycerides, glucose, insulin, and CRP. Multivariate analysis revealed that independent of these factors, low ADPN was associated with eCIMT (OR [95% CI]: 1.505 [1.051-2.153]).
CONCLUSIONS: In the studied population, low adiponectin concentrations are associated with a higher prevalence of subclinical atherosclerosis, independent of traditional cardiovascular risk factors.
Copyright © 2017 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adiponectin; Atherosclerosis; Cardiovascular risk factors; Intima-media thickness; Mexican-Mestizo population

Mesh:

Substances:

Year:  2017        PMID: 28577872     DOI: 10.1016/j.arcmed.2017.01.003

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  4 in total

Review 1.  Inter-organ cross-talk in metabolic syndrome.

Authors:  Christina Priest; Peter Tontonoz
Journal:  Nat Metab       Date:  2019-12-09

2.  The association between serum adiponectin and 3-month outcome after ischemic stroke.

Authors:  Zengliang Wang; Bo Li; Yongxin Wang; Aisha Maimaitili; Hu Qin; Geng Dangmurenjiafu; Shuo Wang
Journal:  Cardiovasc Diabetol       Date:  2019-08-14       Impact factor: 9.951

3.  Association of variant in the ADIPOQ gene and functional study for its role in atherosclerosis.

Authors:  Xinzhong Chen; Yanhong Yuan; Yufeng Gao; Qin Wang; Fei Xie; Dongsheng Xia; Yutao Wei; Ting Xie
Journal:  Oncotarget       Date:  2017-09-23

4.  Association of Adipocytokines With Carotid Intima Media Thickness and Arterial Stiffness in Obstructive Sleep Apnea Patients.

Authors:  Fan Song; Juanjuan Zou; Zhiyuan Song; Huajun Xu; Yinjun Qian; Huaming Zhu; Suru Liu; Jian Guan; Jie Chen; Hongliang Yi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-02       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.